Sleep Apnea
Coverage of Sleep Apnea in the Nexus archive.
- Millions of Americans can get Medicare to cover GLP-1s for weight loss starting this week. Here’s how much it costs.
Millions of Americans can now get Medicare coverage for GLP-1 drugs to treat weight loss starting this week. Previously, Medicare only covered these drugs for conditions like Type 2 diabetes, sleep apnea, and stroke or heart-attack risk.
- Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know
Insurance coverage for GLP-1 weight loss drugs like Zepbound and Wegovy is being dropped by many plans due to high costs, leaving patients to seek alternatives. Patients may retain coverage if the drugs are prescribed for related conditions like sleep apnea or diabetes through prior authorization.
- What is pulmonary hypertension and why would a new GLP-1 help?
A 79-year-old patient with obesity, sleep apnea, and pulmonary hypertension received Eli Lilly's experimental drug retatrutide under a compassionate use program. The White House denied the drug was for President Trump after initial speculation.
- The Appalachian Cities that Never Sleep
A study reveals that 65% of participants in Eastern Kentucky report clinically significant insomnia, with rates rising to 80% for those below the poverty line. The findings challenge previous assumptions about sleep disparities in the region, showing poor sleep is more widespread than initially believed.
- Recurring Sore Throats? Why Experts Say Summer May Be the Best Time to Treat Tonsillitis
Experts from Charlotte Eye Ear Nose & Throat Associates (CEENTA) suggest summer is an optimal time for children with recurring tonsillitis to undergo tonsillectomy, avoiding school disruptions and allowing recovery at home. The procedure, which takes 20-30 minutes under general anesthesia, can alleviate symptoms like sore throat, sleep apnea, and eating difficulties, with most children recovering within days.
- Testosterone is being overprescribed to men — here's who should take it, and when it backfires
Testosterone therapy is overprescribed in the US, with 88% of men in a study not meeting criteria for treatment, risking heart issues, infertility, and long-term dependence. The University of Michigan study highlights improper prescriptions to men with conditions like sleep apnea or prostate cancer, as TRT use has quadrupled since the 1990s.
- 'Godzilla' fat jab tackles arthritis, sleep apnoea and cuts heart risk - as study reveals dramatic weight loss
A 'Godzilla' fat jab has shown potential to treat arthritis, sleep apnea, and reduce heart disease risk, according to a study highlighting significant weight loss outcomes.
- Sleep research led to a new sleep apnea drug
Decades of sleep research at the University of Toronto's Temerty Faculty of Medicine led to the development of a new sleep apnea drug. The drug targets the underlying causes of the condition rather than just symptoms, marking a significant advancement in treatment.
- Disabled man whose comfort eating saw him balloon to nearly 15 stone cures deadly sleep apnoea with old fashioned eating plan
A disabled man cured his deadly sleep apnea by adopting an old-fashioned eating plan, which helped him lose weight after he had ballooned to nearly 15 stone due to comfort eating. The man's weight loss led to the improvement of his sleep apnea condition. This transformation highlights the importance of diet in managing health conditions.
- When does snoring become a problem?
The article discusses when snoring becomes a problem and if it is a sign of a larger issue. Snoring can be a symptom of an underlying health condition. It is essential to identify the cause of snoring to address potential health problems.
- Tech Life
The article discusses a wearable device for sleep apnea, technology to free up hospital beds, and a breast health app. These innovations aim to improve healthcare outcomes. The devices and apps are designed to assist with various health issues.
- New treatment for sleep apnea relieves deadly disorder without bulky breathing device
A new treatment for sleep apnea has been developed that eliminates the need for bulky breathing devices, offering relief for a disorder linked to severe health risks. The innovation marks a significant advancement in managing this deadly condition.